UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Peloton Interactive, Inc. with Losses of $100,000 to Contact the Firm
UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Peloton Interactive, Inc. with Losses of $100,000 to Contact the Firm |
| [31-December-2021] |
LOS ANGELES, Dec. 31, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Peloton Interactive, Inc. ("Peloton" or "the Company") (NASDAQ: PTON) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between December 9, 2020 and November 4, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before January 18, 2022. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Peloton repeatedly claimed to investors that its positive growth and strong business results would continue after the COVID-19 pandemic subsided. The Company allegedly made false statements about its inventory levels and its ability to maintain appropriate inventory to meet demand. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Peloton, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: The Schall Law Firm
SOURCE The Schall Law Firm | ||
Company Codes: NASDAQ-NMS:PTON |
View original content to download multimedia:© 2021 PR Newswire. All Rights Reserved.
NRx Pharmaceuticals (Nasdaq: NRXP): FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir
